Clinical Trial Update: The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the effects of alogliptin combined with Actoplus Met on glucose and lipid metabolism and pancreatic function in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic-associated Fatty Liver Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• ACTOPLUS MET (pioglitazone and metformin hydrochloride)
• Alogliptin (alogliptin)

Snippet

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Conditions: T2DM, MAFLD | Phase 4 | Status: NOT_YET_RECRUITING